RN7SL250P

Across TCGA pan-cancer cohorts, RN7SL250P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RN7SL250P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RN7SL250P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL250P expression acts as an unfavorable survival marker, although some lineages such as UCEC and BRCA show a favorable association.

PAAD, BLCA, and THYM are the cancer types where RN7SL250P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.373	0.636	<.001	75	view →
BLCA	OS	Tertile	IV	0.303	0.604	.034	36	view →
THYM	OS	Tertile	All	0.549	0.974	.001	30	view →
UCEC	OS	Quartile	All	0.976	0.890	.001	30	view →
LUAD	DFS	Tertile	IV	0.357	0.705	.035	27	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
UCS	DFS	Quartile	All	0.184	0.540	.001	24	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
BRCA	OS	Tertile	III,IV	0.889	0.498	.033	18	view →
ESCA	OS	Tertile	II,III,IV	0.105	0.867	.016	18	view →
CESC	OS	Tertile	II,III,IV	0.089	0.553	.015	18	view →
SKCM	DFS	Tertile	II,III,IV	0.976	0.659	.015	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RN7SL250P–PAAD (OS)

Open the PAAD breakdown →